Royce & Associates LP Natera, Inc. Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$86.05 - $119.72 $6.91 Million - $9.61 Million	-80,300 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$91.47 - $124.36 $2.7 Million - $3.67 Million	-29,500 Reduced 26.87%	80,300 $8.15 Million
Q4 2020 Feb 08, 2021	BUY	$66.66 - $111.74 $4.85 Million - $8.13 Million	72,800 Added 196.76%	109,800 $10.9 Million
Q2 2019 Aug 12, 2019	BUY	$17.75 - $27.58 $656,750 - $1.02 Million	37,000 New	37,000 $1.02 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.